Pozen inks licensing agreement with Sanofi
September 04, 2013 at 16:42 PM EDT
Triangle pharma Pozen’s (Nasdaq: POZN) long-running partnership search looks like it’s finally ending...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.